SAFC, a member of the Sigma-Aldrich Group, has completed the expansion of its facility in Jerusalem, Israel, adding manufacturing capabilities in large molecule recombinant proteins and small molecule Active Pharmaceutical Ingredients (APIs) through fermentation, including High Potent APIs (HPAPIs) and secondary metabolites. The 50,000-sq.-ft. cGMP fermentation expansion will focus on niche fermentation of APIs and bulk drugs, producing secondary metabolites (antibiotic-like molecules), cyto...